Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Benzydamine [INN:BAN]
RN: 642-72-8
UNII: 4O21U048EF
InChIKey: CNBGNNVCVSKAQZ-UHFFFAOYSA-N

Note

  • A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat.

Molecular Formula

  • C19-H23-N3-O

Molecular Weight

  • 309.411
 

Classification Codes

  • Anti-Inflammatory Agents
  • Drug / Therapeutic Agent
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Benzydamine [INN:BAN]

Name of Substance

  • Benzydamine
  • Benzydamine [INN:BAN]

MeSH Heading

  • Benzydamine

Synonyms

  • 1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole
  • 5-23-11-00248 (Beilstein Handbook Reference)
  • Bencidamina
  • Bencidamina [INN-Spanish]
  • Benzidamina
  • Benzidamina [DCIT]
  • Benzidamine
  • Benzydamine
  • Benzydaminum
  • Benzydaminum [INN-Latin]
  • BRN 0896536
  • C 1523
  • EINECS 211-388-8
  • UNII-4O21U048EF

Systematic Names

  • 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-
  • 1H-Indazole, 1-benzyl-3-(3-(dimethylamino)propoxy)-
  • Benzydamine

Registry Numbers

CAS Registry Number

  • 642-72-8

FDA UNII

  • 4O21U048EF

Related Registry Number

  • 132-69-4 (mono-hydrochloride)

System Generated Number

  • 0000642728

Structure Descriptors

InChI

InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3

InChIKey

CNBGNNVCVSKAQZ-UHFFFAOYSA-N

Smiles

CN(C)CCCOc1nn(Cc2ccccc2)c3ccccc13

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 109mg/kg (109mg/kg)   Journal of Medicinal Chemistry. Vol. 15, Pg. 471, 1972.
mouse LD50 intravenous 25mg/kg (25mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR		 Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 1285, 1972.
mouse LD50 oral 460mg/kg (460mg/kg) BEHAVIORAL: ATAXIA

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"		 Arzneimittel-Forschung. Drug Research. Vol. 23, Pg. 1266, 1973.
mouse LD50 subcutaneous 445mg/kg (445mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)		 Oyo Yakuri. Pharmacometrics. Vol. 6, Pg. 1285, 1972.
rat LD50 oral 950mg/kg (950mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 15, Pg. 41, 1978.

Physical Properties

Physical Property Value Units Temp (deg C) Source
log P (octanol-water) 4.210 (none)   EST
Atmospheric OH Rate Constant 2.96E-10 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.